Clinical Trials
115 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
St. Jude Children's Research Hospital
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
M.D. Anderson Cancer Center
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Indiana University
A Study of ZW251 in Participants With Advanced Solid Tumors
Zymeworks BC Inc.
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
SONOKID
Assistance Publique - Hôpitaux de Paris
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Children's Oncology Group
JACOB
Children's National Research Institute
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Seattle Children's Hospital
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Baylor College of Medicine
NYMC195
New York Medical College
TICE
Institut Claudius Regaud
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Seattle Children's Hospital
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Nationwide Children's Hospital
EFICATEST
University of Malaga
A Study of DS-9606a in Patients With Advanced Solid Tumors
Daiichi Sankyo
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
AcceleRET-Lung
Hoffmann-La Roche
AflacST1502
Emory University
Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors
Massachusetts General Hospital
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
St. Jude Children's Research Hospital
PRESERVE
Loma Linda University
ASPIRE
Wake Forest University Health Sciences
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
Memorial Sloan Kettering Cancer Center
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
Indiana University
CD30 CAR for CD30+ NSGCT
UNC Lineberger Comprehensive Cancer Center
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Seattle Children's Hospital
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Seattle Children's Hospital
Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Indiana University
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Seattle Children's Hospital
Molecular-Guided Therapy for Childhood Cancer
Milton S. Hershey Medical Center
Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy
Children's Hospital Medical Center, Cincinnati
Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.
Sun Yat-sen University
VIVROVAIRE TR
Centre Francois Baclesse
SCRRYST
Shandong First Medical University
Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor
Shandong First Medical University
RAISN
Heinrich-Heine University, Duesseldorf
DACT-GCT
National Cancer Institute, Slovakia
GERMAN
N.N. Petrov National Medical Research Center of Oncology
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
Memorial Sloan Kettering Cancer Center
AVENTURINE
BioNTech SE
Symptom Management for YA Cancer Survivors
Duke University
P3BEP
University of Sydney
GIG-T
Gustave Roussy, Cancer Campus, Grand Paris
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Cedars-Sinai Medical Center
ARROW
Hoffmann-La Roche
GD2-CAR T Cells for Pediatric Brain Tumours
Bambino Gesù Hospital and Research Institute
Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Alliance for Clinical Trials in Oncology